UMIN ID: UMIN000002166
Registered date:01/08/2009
A genotype-directed dose finding study of irinotecan based on UGT1A1 polymorphisms in metastatic colorectal cancer
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | metastatic colorectal cancer |
| Date of first enrollment | 2009/08/01 |
| Target sample size | 18 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | genotype directed dose finding study of irinotecan |
Outcome(s)
| Primary Outcome | adverse events |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | PS2,3 prior chemotherapy of irinotecan |
Related Information
| Primary Sponsor | kobe University Hospital and Graduate School of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | kobe University Hospital and Graduate School of Medicine |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | |
| Affiliation | kobe University Hospital and Graduate School of Medicine Medical Oncology,Department of Medicine |
| scientific contact | |
| Name | Hironobu Minami |
| Address | 7-5-2kusunoki-cho,chuo-ku,kobe,Japan Japan |
| Telephone | |
| Affiliation | kobe University Hospital and Graduate School of Medicine Medical Oncology,Department of Medicine |